Shigella-specific IgA in saliva of children with bacillary dysentery
- PMID: 1547024
- DOI: 10.1111/j.1574-6968.1992.tb04972.x
Shigella-specific IgA in saliva of children with bacillary dysentery
Abstract
To study the secretory immune response after Shigella infection, the anti-lipopolysaccharide and anti-Shiga-toxin response in saliva, obtained from children with confirmed shigellosis and healthy children, were determined by enzyme-linked immunosorbent assay and by Western blot. Children with infection showed high titers compared to healthy controls. After Shigella dysenteriae type 1 infection a significant change in titer could be observed in a large number of cases, in contrast to Shigella flexneri infection. It appeared that, in children living in endemic areas, infection with one serotype can give a rise in antibody titer to another serotype. This could be ascribed to polyclonal B cell activation since children in endemic areas routinely show relatively high titers to Shigella antigens. We conclude that the dynamics of salivary anti-Shigella LPS and anti-Shiga-toxin in children with dysentery indicate that it can be applied to studies of immune response in shigellosis for epidemiological and vaccination purposes.
Similar articles
-
Mucosal immune response in patients with dysentery.Adv Exp Med Biol. 1995;371B:919-22. Adv Exp Med Biol. 1995. PMID: 7502926 No abstract available.
-
Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery.J Clin Microbiol. 1992 Jul;30(7):1636-41. doi: 10.1128/jcm.30.7.1636-1641.1992. J Clin Microbiol. 1992. PMID: 1629317 Free PMC article.
-
Semiquantitative estimation of Shigella antigen-specific antibodies: correlation with disease severity during shigellosis.APMIS. 1996 Jul-Aug;104(7-8):563-74. doi: 10.1111/j.1699-0463.1996.tb04912.x. APMIS. 1996. PMID: 8920810
-
Shigellosis in Vietnam: seroepidemiologic studies with use of lipopolysaccharide antigens in enzyme immunoassays.Rev Infect Dis. 1991 Mar-Apr;13 Suppl 4:S231-7. doi: 10.1093/clinids/13.supplement_4.s231. Rev Infect Dis. 1991. PMID: 2047643 Review.
-
Inactivated and subunit vaccines to prevent shigellosis.Expert Rev Vaccines. 2009 Dec;8(12):1693-704. doi: 10.1586/erv.09.127. Expert Rev Vaccines. 2009. PMID: 19943764 Review.
Cited by
-
Saliva--a diagnostic window to the body, both in health and in disease.J Med Life. 2009 Apr-Jun;2(2):124-32. J Med Life. 2009. PMID: 20108531 Free PMC article. Review.
-
Sensitivity of oral fluids for detecting influenza A virus in populations of vaccinated and non-vaccinated pigs.Influenza Other Respir Viruses. 2012 Mar;6(2):110-8. doi: 10.1111/j.1750-2659.2011.00276.x. Epub 2011 Jul 21. Influenza Other Respir Viruses. 2012. PMID: 21777397 Free PMC article.
-
Shigella-Controlled Human Infection Models: Current and Future Perspectives.Curr Top Microbiol Immunol. 2024;445:257-313. doi: 10.1007/82_2021_248. Curr Top Microbiol Immunol. 2024. PMID: 35616717 Free PMC article. Review.
-
Lipopolysaccharide-specific antibodies in plasma and stools of children with Shigella-associated leukemoid reaction and hemolytic-uremic syndrome.Clin Diagn Lab Immunol. 1996 Nov;3(6):701-5. doi: 10.1128/cdli.3.6.701-705.1996. Clin Diagn Lab Immunol. 1996. PMID: 8914761 Free PMC article.
-
Detection of Entamoeba histolytica DNA in the saliva of amoebic liver abscess patients who received prior treatment with metronidazole.J Health Popul Nutr. 2008 Dec;26(4):418-25. doi: 10.3329/jhpn.v26i4.1883. J Health Popul Nutr. 2008. PMID: 19069620 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous